Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.81163 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.77597 | 63 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.80134 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.76448 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.70665 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.08401 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.79156 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.77679 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.7762 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.00364 | 66 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.78116 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.77833 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.78444 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.78532 | 63 |